Prevalence and Risk Factors of Cervical Cancer in Nigeria

A tétel rövid nézete
dc.contributor.advisorNagy, Attila
dc.contributor.advisordeptDebreceni Egyetem::Népegészségügyi Karhu_HU
dc.contributor.authorOlatunji, Esther
dc.contributor.departmentDE--Népegészségügyi Karhu_HU
dc.contributor.opponentGergo, Szollosi
dc.contributor.opponentJozsef, Legoza
dc.date.accessioned2022-02-08T10:24:53Z
dc.date.available2022-02-08T10:24:53Z
dc.date.created2021-11-22
dc.description.abstractAmong women, cervical cancer is one of the top causes of mortality from cancer, and it is the 2nd most prevalent malignancy diagnosed in women globally. A multifaceted approach is needed to address this complicated issue, including primary and secondary prevention as well as treatment and access to care improvements. There has to be a call to action from the global health community about the treatment of cervical cancer. New focus on cervical cancer, particularly among government and charitable organizations, is the goal. Human papillomavirus infection has a critical role in the etiology of cervical cancer, according to a variety of studies. DNA sequences from particular HPV strains are found in almost 90% of cervical cancers.hu_HU
dc.description.coursenépegészségügyi MSchu_HU
dc.description.courselangangolhu_HU
dc.description.degreeMSc/MAhu_HU
dc.format.extent42hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/328438
dc.language.isoenhu_HU
dc.subjectPrevalence, Cervical cancer, papsmear, Hpv immunizationhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePrevalence and Risk Factors of Cervical Cancer in Nigeriahu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Public Health)